Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Leukemia 25Leukemia, Myeloid, Acute 23Myelodysplastic Syndromes 22Lymphoma 18Leukemia, Lymphocytic, Chronic, B-Cell 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Lymphoma, Non-Hodgkin 16Leukemia, Myelogenous, Chronic, BCR-ABL Positive 16Hodgkin Disease 15Multiple Myeloma 11Hematologic Neoplasms 11Primary Myelofibrosis 9Myeloproliferative Disorders 9Lymphoma, Mantle-Cell 8Lymphoma, Large B-Cell, Diffuse 8Graft vs Host Disease 8Lymphoma, Follicular 7Lymphoma, B-Cell, Marginal Zone 7Lymphoma, Large-Cell, Immunoblastic 6Leukemia, Myelomonocytic, Juvenile 6Leukemia, Myelomonocytic, Chronic 6Burkitt Lymphoma 6Leukemia, Myeloid, Accelerated Phase 5Waldenstrom Macroglobulinemia 4Neoplasms 4Lymphoma, T-Cell, Cutaneous 4Lymphoma, Extranodal NK-T-Cell 4Leukemia, Neutrophilic, Chronic 4Leukemia, Myeloid, Chronic-Phase 4Congenital Abnormalities 4

Interventions

thymoglobulin 1Mycophenolic Acid 1Cyclosporine 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Neural Tube Defects × thymoglobulin × Clear all
NCT01392989 2019-05-07

Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders

Stanford University

Phase 2 Completed
44 enrolled 13 charts
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Leukemia, Myeloid, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neural Tube Defects

Data powered by HemOnc (CC BY 4.0) Colophon âš¡